About Rapid Micro Biosystems, Inc.
https://www.rapidmicrobio.comRapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in North America, Europe, and Asia.
CEO
Robert G. Spignesi Jr.
Compensation Summary
(Year 2024)
ETFs Holding This Stock
Summary
Showing Top 3 of 16
Ratings Snapshot
Rating : C-
Price Target
Institutional Ownership
BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC
Shares:8.43M
Value:$31.04M
KENNEDY LEWIS MANAGEMENT LP
Shares:4.94M
Value:$18.18M
ABG-WTT GLOBAL LIFE SCIENCE CAPITAL PARTNERS GP LTD
Shares:1.85M
Value:$6.8M
Summary
Showing Top 3 of 36
About Rapid Micro Biosystems, Inc.
https://www.rapidmicrobio.comRapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in North America, Europe, and Asia.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $7.84M ▲ | $13.65M ▼ | $-11.51M ▲ | -146.78% ▲ | $-0.25 ▲ | $-10.28M ▲ |
| Q2-2025 | $7.26M ▲ | $14.1M ▲ | $-11.86M ▼ | -163.29% ▼ | $-0.27 ▼ | $-11.04M ▼ |
| Q1-2025 | $7.21M ▼ | $12.06M ▲ | $-11.26M ▼ | -156.32% ▼ | $-0.26 ▼ | $-10.81M ▼ |
| Q4-2024 | $8.22M ▲ | $11.21M ▼ | $-9.67M ▲ | -117.62% ▲ | $-0.22 ▲ | $-9.36M ▲ |
| Q3-2024 | $7.6M | $12.66M | $-11.32M | -148.91% | $-0.26 | $-11.31M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $41.25M ▲ | $84.41M ▲ | $40.08M ▲ | $44.33M ▼ |
| Q2-2025 | $31.25M ▼ | $75.59M ▼ | $21.04M ▲ | $54.55M ▼ |
| Q1-2025 | $41.67M ▼ | $85.43M ▼ | $19.94M ▼ | $65.49M ▼ |
| Q4-2024 | $50.73M ▼ | $98.17M ▼ | $22.82M ▲ | $75.35M ▼ |
| Q3-2024 | $60.83M | $105.84M | $21.47M | $84.37M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $-11.51M ▲ | $-9.05M ▲ | $-9.58M ▼ | $19.25M ▲ | $613K ▲ | $-9.12M ▲ |
| Q2-2025 | $-11.86M ▼ | $-9.7M ▼ | $9.34M ▼ | $-298K ▼ | $-573K ▼ | $-10.07M ▼ |
| Q1-2025 | $-11.26M ▼ | $-9.06M ▲ | $10.68M ▲ | $379K ▲ | $2M ▲ | $-9.38M ▲ |
| Q4-2024 | $-9.67M ▲ | $-9.91M ▼ | $4.86M ▲ | $-6K ▼ | $-5.05M ▲ | $-10.01M ▼ |
| Q3-2024 | $-11.32M | $-8.6M | $-6.54M | $61K | $-15.08M | $-8.82M |
Revenue by Products
| Product | Q4-2024 | Q1-2025 | Q2-2025 | Q3-2025 |
|---|---|---|---|---|
 Product | $10.00M ▲ | $10.00M ▲ | $10.00M ▲ | $10.00M ▲ |
 Service | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
Revenue by Geography
| Region | Q4-2024 | Q1-2025 | Q2-2025 | Q3-2025 |
|---|---|---|---|---|
 All Other Countries | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
 GERMANY | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
 JAPAN | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
 SWITZERLAND | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
 UNITED STATES | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
CEO
Robert G. Spignesi Jr.
Compensation Summary
(Year 2024)
ETFs Holding This Stock
Summary
Showing Top 3 of 16
Ratings Snapshot
Rating : C-
Price Target
Institutional Ownership
BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC
Shares:8.43M
Value:$31.04M
KENNEDY LEWIS MANAGEMENT LP
Shares:4.94M
Value:$18.18M
ABG-WTT GLOBAL LIFE SCIENCE CAPITAL PARTNERS GP LTD
Shares:1.85M
Value:$6.8M
Summary
Showing Top 3 of 36